Knowledge of pediatricians working in emergency sector about anaphylaxis treatment
Main Author: | |
---|---|
Publication Date: | 2018 |
Other Authors: | |
Format: | Article |
Language: | por |
Source: | ABCS Health Sciences (Online) |
Download full: | https://www.portalnepas.org.br/abcshs/article/view/983 |
Summary: | Introduction: Anaphylaxis is a severe, acute and potentially fatal systemic reaction. It presents several triggers and different mechanisms, however, the acute treatment is the same in all the cases. Objective: To evaluate the knowledge about treatment of anaphylaxis and anaphylactic shock (AS) of pediatricians who works in the pediatric emergency sector. Methods: Cross-sectional study through the use of a multiplechoice questionnaire with 10 questions about the treatment of anaphylaxis and AS. All the emergency room pediatricians of a general pediatric hospital were invited. Results: Fifty of fifty-ne pediatricians agreed to take part of the study. The mean of right answers was 6.32 and median of 7 (minimum 2 and maximum 10). There was an appropriate recognition about the drug of choice to initiate the treatment of anaphylaxis and AS in 96% and 92%, respectively. On the route of adrenaline administration, the adequacy of the answers was 64%. Regarding to adrenaline dose 70% were right, however the recognition of the maximum dose was 44%. When asked about the interval to repeat the adrenaline, 38% responded correctly. About adjuvant therapies to treat AS the score was 74% and 60% when questioned about the drug that prevents biphasic anaphylactic reaction. In relation to the observation time, 54% answered the appropriate period. The right answers about available self-injectable adrenaline presentations were 40%. Conclusion: There were difficulty to recognize the maximum dose, self-injectable adrenaline dose and the correct time to repeat the adrenaline/medication, which increase the risk of overdose and adverse effects. |
id |
FMABC_4caef2c8b454b721c9ef4b7a7c9a4e64 |
---|---|
oai_identifier_str |
oai:ojs.emnuvens.com.br:article/983 |
network_acronym_str |
FMABC |
network_name_str |
ABCS Health Sciences (Online) |
repository_id_str |
|
spelling |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatmentConhecimento de pediatras que atuam em urgências e emergências sobre tratamento da anafilaxiaanaphylaxisepinephrinepediatricsemergency treatmentanafilaxiaepinefrinapediatriatratamento de emergênciaIntroduction: Anaphylaxis is a severe, acute and potentially fatal systemic reaction. It presents several triggers and different mechanisms, however, the acute treatment is the same in all the cases. Objective: To evaluate the knowledge about treatment of anaphylaxis and anaphylactic shock (AS) of pediatricians who works in the pediatric emergency sector. Methods: Cross-sectional study through the use of a multiplechoice questionnaire with 10 questions about the treatment of anaphylaxis and AS. All the emergency room pediatricians of a general pediatric hospital were invited. Results: Fifty of fifty-ne pediatricians agreed to take part of the study. The mean of right answers was 6.32 and median of 7 (minimum 2 and maximum 10). There was an appropriate recognition about the drug of choice to initiate the treatment of anaphylaxis and AS in 96% and 92%, respectively. On the route of adrenaline administration, the adequacy of the answers was 64%. Regarding to adrenaline dose 70% were right, however the recognition of the maximum dose was 44%. When asked about the interval to repeat the adrenaline, 38% responded correctly. About adjuvant therapies to treat AS the score was 74% and 60% when questioned about the drug that prevents biphasic anaphylactic reaction. In relation to the observation time, 54% answered the appropriate period. The right answers about available self-injectable adrenaline presentations were 40%. Conclusion: There were difficulty to recognize the maximum dose, self-injectable adrenaline dose and the correct time to repeat the adrenaline/medication, which increase the risk of overdose and adverse effects.Introdução: Anafilaxia é uma reação sistêmica grave, aguda e potencialmente fatal. Apresenta vários desencadeantes e mecanismos diferentes, entretanto, o tratamento agudo é igual em todos os casos. Objetivo: Avaliar o conhecimento sobre tratamento da anafilaxia e choque anafilático (CA) de pediatras que atuam em setor de emergência pediátrica. Métodos: Estudo transversal através da aplicação de questionário de múltiplas escolhas com 10 perguntas sobre tratamento da anafilaxia e CA. Foram convidados todos os pediatras do Pronto Socorro de um Hospital Público Pediátrico. Resultados: Cinquenta entre 51 pediatras concordaram em participar do estudo. A média de acertos foi 6,32 com mediana de 7 (mínimo 2 e máximo 10). Houve reconhecimento adequado dos pediatras sobre a droga de escolha para iniciar o tratamento da anafilaxia e CA em 96% e 92%, respectivamente. Sobre a via de administração da adrenalina, a adequação das respostas foi de 64%. Em relação à dose de adrenalina, 70% identificaram corretamente, porém, o conhecimento sobre a dose máxima foi de 44%. Ao perguntar o intervalo para repetir a adrenalina, 38% responderam corretamente. Perguntou-se sobre terapias adjuvantes no tratamento do CA com 74% de acerto. Sobre a droga que previne a reação anafilática bifásica, 60% responderam corretamente. Quanto ao tempo de observação, 54% responderam o período adequado. O acerto sobre apresentações disponíveis de adrenalina autoinjetável foi de 40%. Conclusão: Houve dificuldade principalmente em reconhecer dose máxima, dose de adrenalina autoinjetável e tempo necessário para ser repetida, o que aumenta o risco de superdosagem e seus efeitos adversos.Núcleo de Estudos, Pesquisa e Assessoria à Saúde (NEPAS)2018-05-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfapplication/pdfapplication/pdfapplication/pdfimage/jpegimage/jpegapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfimage/jpegimage/jpegimage/jpegapplication/pdfapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfapplication/pdfapplication/pdfhttps://www.portalnepas.org.br/abcshs/article/view/98310.7322/abcshs.v43i1.983ABCS Health Sciences; Vol. 43 No. 1 (2018)ABCS Health Sciences; v. 43 n. 1 (2018)2357-81142318-4965reponame:ABCS Health Sciences (Online)instname:Faculdade de Medicina do ABC (FMABC)instacron:FMABCporhttps://www.portalnepas.org.br/abcshs/article/view/983/797https://www.portalnepas.org.br/abcshs/article/view/983/925https://www.portalnepas.org.br/abcshs/article/view/983/926https://www.portalnepas.org.br/abcshs/article/view/983/927https://www.portalnepas.org.br/abcshs/article/view/983/928https://www.portalnepas.org.br/abcshs/article/view/983/929https://www.portalnepas.org.br/abcshs/article/view/983/930https://www.portalnepas.org.br/abcshs/article/view/983/933https://www.portalnepas.org.br/abcshs/article/view/983/999https://www.portalnepas.org.br/abcshs/article/view/983/1000https://www.portalnepas.org.br/abcshs/article/view/983/1001https://www.portalnepas.org.br/abcshs/article/view/983/1002https://www.portalnepas.org.br/abcshs/article/view/983/1003https://www.portalnepas.org.br/abcshs/article/view/983/1004https://www.portalnepas.org.br/abcshs/article/view/983/1005https://www.portalnepas.org.br/abcshs/article/view/983/1006https://www.portalnepas.org.br/abcshs/article/view/983/1010https://www.portalnepas.org.br/abcshs/article/view/983/1011https://www.portalnepas.org.br/abcshs/article/view/983/1012https://www.portalnepas.org.br/abcshs/article/view/983/1013Copyright (c) 2018 João Carlos Pina Faria, Tifani Dawidowicz Fernandesinfo:eu-repo/semantics/openAccessFaria, João Carlos PinaFernandes, Tifani Dawidowicz2021-07-13T20:48:19Zoai:ojs.emnuvens.com.br:article/983Revistahttp://www.portalnepas.org.br/abcshsPUBhttp://www.portalnepas.org.br/abcshs/oairicardo.souto@fmabc.br2357-81142318-4965opendoar:2021-07-13T20:48:19ABCS Health Sciences (Online) - Faculdade de Medicina do ABC (FMABC)false |
dc.title.none.fl_str_mv |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment Conhecimento de pediatras que atuam em urgências e emergências sobre tratamento da anafilaxia |
title |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment |
spellingShingle |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment Faria, João Carlos Pina anaphylaxis epinephrine pediatrics emergency treatment anafilaxia epinefrina pediatria tratamento de emergência |
title_short |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment |
title_full |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment |
title_fullStr |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment |
title_full_unstemmed |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment |
title_sort |
Knowledge of pediatricians working in emergency sector about anaphylaxis treatment |
author |
Faria, João Carlos Pina |
author_facet |
Faria, João Carlos Pina Fernandes, Tifani Dawidowicz |
author_role |
author |
author2 |
Fernandes, Tifani Dawidowicz |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Faria, João Carlos Pina Fernandes, Tifani Dawidowicz |
dc.subject.por.fl_str_mv |
anaphylaxis epinephrine pediatrics emergency treatment anafilaxia epinefrina pediatria tratamento de emergência |
topic |
anaphylaxis epinephrine pediatrics emergency treatment anafilaxia epinefrina pediatria tratamento de emergência |
description |
Introduction: Anaphylaxis is a severe, acute and potentially fatal systemic reaction. It presents several triggers and different mechanisms, however, the acute treatment is the same in all the cases. Objective: To evaluate the knowledge about treatment of anaphylaxis and anaphylactic shock (AS) of pediatricians who works in the pediatric emergency sector. Methods: Cross-sectional study through the use of a multiplechoice questionnaire with 10 questions about the treatment of anaphylaxis and AS. All the emergency room pediatricians of a general pediatric hospital were invited. Results: Fifty of fifty-ne pediatricians agreed to take part of the study. The mean of right answers was 6.32 and median of 7 (minimum 2 and maximum 10). There was an appropriate recognition about the drug of choice to initiate the treatment of anaphylaxis and AS in 96% and 92%, respectively. On the route of adrenaline administration, the adequacy of the answers was 64%. Regarding to adrenaline dose 70% were right, however the recognition of the maximum dose was 44%. When asked about the interval to repeat the adrenaline, 38% responded correctly. About adjuvant therapies to treat AS the score was 74% and 60% when questioned about the drug that prevents biphasic anaphylactic reaction. In relation to the observation time, 54% answered the appropriate period. The right answers about available self-injectable adrenaline presentations were 40%. Conclusion: There were difficulty to recognize the maximum dose, self-injectable adrenaline dose and the correct time to repeat the adrenaline/medication, which increase the risk of overdose and adverse effects. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-05-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.portalnepas.org.br/abcshs/article/view/983 10.7322/abcshs.v43i1.983 |
url |
https://www.portalnepas.org.br/abcshs/article/view/983 |
identifier_str_mv |
10.7322/abcshs.v43i1.983 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.portalnepas.org.br/abcshs/article/view/983/797 https://www.portalnepas.org.br/abcshs/article/view/983/925 https://www.portalnepas.org.br/abcshs/article/view/983/926 https://www.portalnepas.org.br/abcshs/article/view/983/927 https://www.portalnepas.org.br/abcshs/article/view/983/928 https://www.portalnepas.org.br/abcshs/article/view/983/929 https://www.portalnepas.org.br/abcshs/article/view/983/930 https://www.portalnepas.org.br/abcshs/article/view/983/933 https://www.portalnepas.org.br/abcshs/article/view/983/999 https://www.portalnepas.org.br/abcshs/article/view/983/1000 https://www.portalnepas.org.br/abcshs/article/view/983/1001 https://www.portalnepas.org.br/abcshs/article/view/983/1002 https://www.portalnepas.org.br/abcshs/article/view/983/1003 https://www.portalnepas.org.br/abcshs/article/view/983/1004 https://www.portalnepas.org.br/abcshs/article/view/983/1005 https://www.portalnepas.org.br/abcshs/article/view/983/1006 https://www.portalnepas.org.br/abcshs/article/view/983/1010 https://www.portalnepas.org.br/abcshs/article/view/983/1011 https://www.portalnepas.org.br/abcshs/article/view/983/1012 https://www.portalnepas.org.br/abcshs/article/view/983/1013 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 João Carlos Pina Faria, Tifani Dawidowicz Fernandes info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 João Carlos Pina Faria, Tifani Dawidowicz Fernandes |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf image/jpeg image/jpeg application/pdf application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf image/jpeg image/jpeg image/jpeg application/pdf application/pdf application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Núcleo de Estudos, Pesquisa e Assessoria à Saúde (NEPAS) |
publisher.none.fl_str_mv |
Núcleo de Estudos, Pesquisa e Assessoria à Saúde (NEPAS) |
dc.source.none.fl_str_mv |
ABCS Health Sciences; Vol. 43 No. 1 (2018) ABCS Health Sciences; v. 43 n. 1 (2018) 2357-8114 2318-4965 reponame:ABCS Health Sciences (Online) instname:Faculdade de Medicina do ABC (FMABC) instacron:FMABC |
instname_str |
Faculdade de Medicina do ABC (FMABC) |
instacron_str |
FMABC |
institution |
FMABC |
reponame_str |
ABCS Health Sciences (Online) |
collection |
ABCS Health Sciences (Online) |
repository.name.fl_str_mv |
ABCS Health Sciences (Online) - Faculdade de Medicina do ABC (FMABC) |
repository.mail.fl_str_mv |
ricardo.souto@fmabc.br |
_version_ |
1836732274537660416 |